However, undetermined factors other than anti-AQP4 antibodies including inflammatory mediators, T and B cell involvement and blood-brain barrier (BBB) disruption, is required to trigger the development of the disease, because the presence of serum anti-AQP4 antibodies alone is insufficient to cause NMO without inflammation [10–12]. The gene discussed is AQP4; the disease is neuromyelitis optica.